Cargando...
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...
Gardado en:
| Publicado en: | Per Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186476/ https://ncbi.nlm.nih.gov/pubmed/34086487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme-2020-0183 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|